Source:http://linkedlifedata.com/resource/pubmed/id/12684082
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2003-4-9
|
pubmed:abstractText |
Metastasis is largely an unsuccessful process, because the majority of disseminating tumor cells demise shortly after reaching distant organs. Therefore, survival is essential for disseminating tumor cells to establish metastases. During metastasis, interaction between tumor and host cells leads to the production of nitric oxide (NO). An increasing amount of evidence suggests that NO regulates tumor-cell survival and influences cancer metastasis. The ultimate effect of NO on tumor-cell survival is dictated by multiple factors, including the levels of NO production and genetic and epigenetic makeup of the tumor cells. Also, expression of inducible nitric oxide synthase (NOS) II has the potential to produce NO at a toxic level and tumor-cell death via apoptosis. Yet, impaired NOS II expression during tumor progression may lead to decreased NO production, which may be insufficient to produce significant cytotoxic effects, and the subsequent low level of NO production may cause induction of NO resistance, and the NO-resistant tumor cells may usurp NO to undergo progression. Thus, restoration of NOS II expression and reversal of NO resistance may prevent tumor growth and metastasis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals,
http://linkedlifedata.com/resource/pubmed/chemical/NOS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0891-5849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
969-86
|
pubmed:dateRevised |
2011-10-27
|
pubmed:meshHeading |
pubmed-meshheading:12684082-Animals,
pubmed-meshheading:12684082-Apoptosis,
pubmed-meshheading:12684082-Cell Survival,
pubmed-meshheading:12684082-Disease Progression,
pubmed-meshheading:12684082-Free Radicals,
pubmed-meshheading:12684082-Humans,
pubmed-meshheading:12684082-Models, Biological,
pubmed-meshheading:12684082-Neoplasm Metastasis,
pubmed-meshheading:12684082-Neoplasms,
pubmed-meshheading:12684082-Nitric Oxide,
pubmed-meshheading:12684082-Nitric Oxide Synthase,
pubmed-meshheading:12684082-Nitric Oxide Synthase Type II
|
pubmed:year |
2003
|
pubmed:articleTitle |
Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency.
|
pubmed:affiliation |
Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. kepxie@mail.mdanderson.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|